FDA Inspection 1169289 — CooperVision, Inc.
The FDA completed an inspection of CooperVision, Inc. on May 4, 2022 in Scottsville, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 4, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Scottsville, NY (United States)